-+ 0.00%
-+ 0.00%
-+ 0.00%

AB&B Bio-Tech Q3 2026 Net Profit Rises 16% to RMB 59 Million; Revenue Climbs to RMB 322 Million

PUBT·11/17/2026 10:18:36
Listen to the news
AB&B Bio-Tech Q3 2026 Net Profit Rises 16% to RMB 59 Million; Revenue Climbs to RMB 322 Million
  • AB&B Bio-Tech’s third-quarter 2026 net profit rose 16% year over year to approximately RMB 59 million.
  • Revenue increased year over year to approximately RMB 322 million.
  • Profit growth benefited from higher capacity utilization and lower administrative and research and development expenses.
  • Trading in its H Shares remains suspended until further notice, following the suspension effective April 1, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261117-12415958), on November 17, 2026, and is solely responsible for the information contained therein.